Funded Tech Companies

Ayala Pharmaceuticals

Ayala Pharmaceuticals, based in Wilmington, received investment capital from SBI Holding, Harel Insurance and Novartis Venture Fund.

Company Overview

Contact Information

Company Background Information

Overview

Ayala (Nasdaq: AYLA) is a clinical stage precision oncology company dedicated to developing targeted therapies for genomically defined, clinically underserved cancers. We look to target rare and unique cancers, in which the Notch activation pathway has been dysregulated. Notch is a proven oncogenic driver in defined cancers.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/7/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Roni Mamluk

        

Chief Financial Officer

Yossi Maimon

        

Chief Medical Officer

Andrea Vergara-Silva

        

Vice President

David Caron

        

VP - Bus. Development

Dana Gelbaum

        

VP - Human Resources

Irit Klipper-Avni

        

VP - R & D

Joel Kaye

        

Company Investors

• SBI Holding
• Harel Insurance
• Novartis Venture Fund
• aMoon Partners
• Israel Biotech Fund

Browse more funded tech companies:

Aya | Ayalogic

Share this article

About Our Venture Capital Database

The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary